Michael Martin Breen Gt Biopharma, Inc. (GTBP) insider trading activity

Michael Martin Breen is Executive Chairman/Interim CEO of GT Biopharma, Inc.. Currently has a direct ownership of 856,218 shares of GTBP, which is worth approximately $2.41 Million. The most recent transaction as insider was on Aug 11, 2023, when has been sold 200,000 shares (Common Stock) at a price of $0.29 per share, resulting in proceeds of $57,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 856K

0% 3M change

0% 12M change

Total Value Held $2.41 Million

Michael Martin Breen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 11 2023	BUY Grant, award, or other acquisition	$57,999 $0.29 p/Share	200,000 Added 18.94%	856,218 Common Stock
Apr 11 2023	BUY Open market or private purchase	$25,000 $0.5 p/Share	50,000 Added 7.08%	656,218 Common Stock
Jul 15 2022	BUY Grant, award, or other acquisition	-	278,058 Added 31.44%	606,218 Common Stock
Feb 25 2021	BUY Conversion of derivative security	$170,347 $3.4 p/Share	50,102 Added 13.25%	328,160 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	278,058 Added 50.0%	278,058 Common Stock

Also insider at

CRKR

Creek Road Miners, Inc. Financial Services

Director

MMB